Literature DB >> 34206873

Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex.

Atsumi Nitta1, Naotaka Izuo1, Kohei Hamatani1, Ryo Inagaki1, Yuka Kusui1, Kequan Fu1,2, Takashi Asano1, Youta Torii3, Chikako Habuchi3, Hirotaka Sekiguchi3, Shuji Iritani3, Shin-Ichi Muramatsu4,5, Norio Ozaki3, Yoshiaki Miyamoto1.   

Abstract

Piccolo, a presynaptic cytomatrix protein, plays a role in synaptic vesicle trafficking in the presynaptic active zone. Certain single-nucleotide polymorphisms of the Piccolo-encoding gene PCLO are reported to be associated with mental disorders. However, a few studies have evaluated the relationship between Piccolo dysfunction and psychotic symptoms. Therefore, we investigated the neurophysiological and behavioral phenotypes in mice with Piccolo suppression in the medial prefrontal cortex (mPFC). Downregulation of Piccolo in the mPFC reduced regional synaptic proteins, accompanied with electrophysiological impairments. The Piccolo-suppressed mice showed an enhanced locomotor activity, impaired auditory prepulse inhibition, and cognitive dysfunction. These abnormal behaviors were partially ameliorated by the antipsychotic drug risperidone. Piccolo-suppressed mice received mild social defeat stress showed additional behavioral despair. Furthermore, the responses of these mice to extracellular glutamate and dopamine levels induced by the optical activation of mPFC projection in the dorsal striatum (dSTR) were inhibited. Similarly, the Piccolo-suppressed mice showed decreased depolarization-evoked glutamate and -aminobutyric acid elevations and increased depolarization-evoked dopamine elevation in the dSTR. These suggest that Piccolo regulates neurotransmission at the synaptic terminal of the projection site. Reduced neuronal connectivity in the mPFC-dSTR pathway via suppression of Piccolo in the mPFC may induce behavioral impairments observed in schizophrenia.

Entities:  

Keywords:  dorsal striatum; medial prefrontal cortex; optogenetics; piccolo; presynaptic cytomatrix protein; schizophrenia

Year:  2021        PMID: 34206873     DOI: 10.3390/jpm11070607

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  49 in total

1.  An unusual C(2)-domain in the active-zone protein piccolo: implications for Ca(2+) regulation of neurotransmitter release.

Authors:  S H Gerber; J Garcia; J Rizo; T C Südhof
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation.

Authors:  T Paus; M A Castro-Alamancos; M Petrides
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

3.  Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.

Authors:  F M Benes; J McSparren; E D Bird; J P SanGiovanni; S L Vincent
Journal:  Arch Gen Psychiatry       Date:  1991-11

Review 4.  Synaptic vesicle pools and dynamics.

Authors:  AbdulRasheed A Alabi; Richard W Tsien
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

5.  Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 region.

Authors:  Daisuke Ibi; Atsumi Nitta; Kumiko Ishige; Xiaobo Cen; Tomohiro Ohtakara; Toshitaka Nabeshima; Yoshihisa Ito
Journal:  Neurochem Int       Date:  2009-09-17       Impact factor: 3.921

6.  Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

Authors:  R Bartha; P C Williamson; D J Drost; A Malla; T J Carr; L Cortese; G Canaran; R J Rylett; R W Neufeld
Journal:  Arch Gen Psychiatry       Date:  1997-10

7.  The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study.

Authors:  K Uno; D Nishizawa; S Seo; K Takayama; S Matsumura; N Sakai; K Ohi; T Nabeshima; R Hashimoto; N Ozaki; J Hasegawa; N Sato; F Tanioka; H Sugimura; K-I- Fukuda; S Higuchi; H Ujike; T Inada; N Iwata; I Sora; M Iyo; N Kondo; M-J Won; N Naruse; K Uehara-Aoyama; M Itokawa; M Yamada; K Ikeda; Y Miyamoto; A Nitta
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

Review 8.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

9.  Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; David W Volk; Stephen M Eggan; Karoly Mirnics; Joseph N Pierri; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  J Neurosci       Date:  2003-07-16       Impact factor: 6.167

10.  A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.

Authors:  Minae Niwa; Atsumi Nitta; Hiroyuki Mizoguchi; Yasutomo Ito; Yukihiro Noda; Taku Nagai; Toshitaka Nabeshima
Journal:  J Neurosci       Date:  2007-07-11       Impact factor: 6.167

View more
  4 in total

1.  Knockdown of Piccolo in the Nucleus Accumbens Suppresses Methamphetamine-Induced Hyperlocomotion and Conditioned Place Preference in Mice.

Authors:  Yuka Kusui; Naotaka Izuo; Kyosuke Uno; Bin Ge; Shin-Ichi Muramatsu; Atsumi Nitta
Journal:  Neurochem Res       Date:  2022-07-29       Impact factor: 4.414

2.  Multi-Omics Analysis Reveals Myelin, Presynaptic and Nicotinate Alterations in the Hippocampus of G72/G30 Transgenic Mice.

Authors:  Michaela D Filiou; Larysa Teplytska; Markus Nussbaumer; David-M Otte; Andreas Zimmer; Christoph W Turck
Journal:  J Pers Med       Date:  2022-02-09

3.  Ablation of the Presynaptic Protein Mover Impairs Learning Performance and Decreases Anxiety Behavior in Mice.

Authors:  Eva Maria Schleicher; Thomas A Bayer; Trendelina Iseni; Frederik Wilhelm Ott; Jannek Moritz Wagner; Julio S Viotti; Thomas Dresbach; Yvonne Bouter
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

4.  Psychoneurobiology Research and Personalized Treatment of Schizophrenia.

Authors:  Tomiki Sumiyoshi
Journal:  J Pers Med       Date:  2021-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.